FREQUENT HOMOZYGOUS DELETIONS OF TYPE I INTERFERON GENES IN PLEURAL MESOTHELIOMA CONFER SENSITIVITY TO ONCOLYTIC MEASLES VIRUS.

[1]  E. Thompson,et al.  Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy , 2018, Journal of the National Cancer Institute.

[2]  J. Bell,et al.  Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy , 2018, EBioMedicine.

[3]  E. Chiocca,et al.  Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells. , 2018, Oncoimmunology.

[4]  J. Aerts,et al.  Novel insights into mesothelioma biology and implications for therapy , 2017, Nature Reviews Cancer.

[5]  E. Galanis,et al.  Potential and clinical translation of oncolytic measles viruses , 2017, Expert opinion on biological therapy.

[6]  F. Tangy,et al.  Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells , 2016, Oncoimmunology.

[7]  J. Zucman‐Rossi,et al.  Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma , 2016, Clinical Cancer Research.

[8]  S. Pastorino,et al.  High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma , 2016, Proceedings of the National Academy of Sciences.

[9]  F. Tangy,et al.  Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response , 2015, Oncotarget.

[10]  F. Tangy,et al.  Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus , 2015 .

[11]  A. Oberg,et al.  Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. , 2015, Cancer research.

[12]  A. Marchini,et al.  Oncolytic parvoviruses: from basic virology to clinical applications , 2015, Virology Journal.

[13]  M. Diamond,et al.  Deficient IFN Signaling by Myeloid Cells Leads to MAVS-Dependent Virus-Induced Sepsis , 2014, PLoS pathogens.

[14]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[15]  E. Chiocca,et al.  Glioma virus therapies between bench and bedside. , 2014, Neuro-oncology.

[16]  F. Galateau-Sallé,et al.  Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition , 2014, Clinical Cancer Research.

[17]  U. Lauer,et al.  Primary resistance phenomena to oncolytic measles vaccine viruses. , 2013, International journal of oncology.

[18]  F. Tangy,et al.  Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells , 2013, Oncoimmunology.

[19]  F. Tangy,et al.  Antitumor Virotherapy by Attenuated Measles Virus (MV) , 2013, Biology.

[20]  F. Tangy,et al.  Measles Virus Vaccine–Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells , 2013, Clinical Cancer Research.

[21]  F. Stubenrauch,et al.  Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis , 2013, Journal of Virology.

[22]  J. Bond,et al.  Measles virus causes immunogenic cell death in human melanoma , 2011, Gene Therapy.

[23]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[24]  S. Russell,et al.  ONCOLYTIC VIROTHERAPY , 2012, Nature Biotechnology.

[25]  F. Galateau-Sallé,et al.  Molecular changes in mesothelioma with an impact on prognosis and treatment. , 2012, Archives of pathology & laboratory medicine.

[26]  Christopher T. Jones,et al.  A diverse array of gene products are effectors of the type I interferon antiviral response , 2011, Nature.

[27]  A. Krasinskas,et al.  The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. , 2011, American journal of clinical pathology.

[28]  A. Scherpereel,et al.  Identification of novel markers for the diagnosis of malignant pleural mesothelioma. , 2011, The American journal of pathology.

[29]  D. Knight,et al.  Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. , 2009, American journal of respiratory and critical care medicine.

[30]  F. Galateau-Sallé,et al.  Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas , 2008, Virchows Archiv.

[31]  F. Tangy,et al.  Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response. , 2008, Cancer research.

[32]  Simion I. Chiosea,et al.  Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas , 2008, Modern Pathology.

[33]  C. Shuler,et al.  Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[34]  S. Russell,et al.  High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus , 2004, Cancer Research.

[35]  L. Mollet,et al.  A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice , 2003, Journal of Virology.

[36]  Z. Fishelson,et al.  Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. , 2003, Molecular immunology.

[37]  M. Ladanyi,et al.  Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  J. Hiscott,et al.  Transcriptional Profiling of Interferon Regulatory Factor 3 Target Genes: Direct Involvement in the Regulation of Interferon-Stimulated Genes , 2002, Journal of Virology.

[39]  T. Taniguchi,et al.  Gene induction pathways mediated by distinct IRFs during viral infection. , 2001, Biochemical and biophysical research communications.

[40]  J. Fletcher,et al.  Codeletion of p15 and p16 in primary malignant mesothelioma. , 1995, Oncogene.

[41]  O. Olopade,et al.  p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. , 1994, Cancer research.

[42]  Christopher D. Richardson,et al.  The human CD46 molecule is a receptor for measles virus (Edmonston strain) , 1993, Cell.

[43]  D. Gerlier,et al.  Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus , 1993, Journal of virology.